Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug;40(4):1285-1296.
doi: 10.1007/s10753-017-0572-y.

Oxyresveratrol Is a Phytoestrogen Exerting Anti-inflammatory Effects Through NF-κB and Estrogen Receptor Signaling

Affiliations

Oxyresveratrol Is a Phytoestrogen Exerting Anti-inflammatory Effects Through NF-κB and Estrogen Receptor Signaling

Jing Wei et al. Inflammation. 2017 Aug.

Abstract

Recent studies suggest an anti-inflammatory activity of oxyresveratrol, a stilbene extracted from Cortex mori root used in traditional Chinese medicine that also presents estrogen-like activity. We herein tested the hypothesis that oxyreservatrol exerts an anti-inflammatory effect through its estrogenic-like function. In MCF-7 cells, oxyresveratrol significantly induced proliferation, which was accompanied with estrogen receptor (ER)-mediated transcriptional activation, increased estrogen-targeted gene expression (e.g., pS2, PGR, and CTSD), and increased ERα/β proteins. The estrogen-like effect of oxyresveratrol was reversed by the ER inhibitor ICI 182780. Strong ER-binding activities of oxyresveratrol were revealed by negative docking scores. The LPS-induced inflammatory response (e.g., upregulated IκB-α phosphorylation, NF-κB nuclear translocation, and cytokine messenger RNA expression) was significantly suppressed in an ER-dependent manner by oxyresveratrol in RAW264.7 cells. These results suggest that oxyresveratrol may function as an ER agonist and modulate NF-κB signaling.

Keywords: Cortex Mori; NF-κB signaling pathways; anti-inflammatory; estrogen; oxyresveratrol.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Zhongguo Zhong Yao Za Zhi. 2014 Dec;39(23):4526-31 - PubMed
    1. Nat Prod Res. 2005 Feb;19(2):177-82 - PubMed
    1. J Pharm Pharmacol. 2003 Dec;55(12):1695-700 - PubMed
    1. Mediators Inflamm. 2014;2014:615917 - PubMed
    1. J Am Coll Cardiol. 2000 Mar 1;35(3):569-82 - PubMed

MeSH terms

LinkOut - more resources